Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | RECQL | P46063 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | GLA | P06280 | 1/20 | 0.30 |
| ▸ | CA3 | P07451 | 1/20 | 0.30 |
| ▸ | CA4 | P22748 | 1/20 | 0.30 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.30 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9510289 | 0.78 | — | — | |
| SCHEMBL29926801 | 0.76 | ALDH1A1 (0.32) | TDP1ALDH1A1GAAMAPK1 | |
| SCHEMBL3682860 | 0.74 | TP53 (0.38) | ALDH1A1GAAMAPK1FFAR1 | |
| SCHEMBL28598231 | 0.74 | LOXL2 (0.32) | ALDH1A1MAPK1 | |
| SCHEMBL2272019 | 0.74 | ALDH1A1 (0.31) | TSHRALDH1A1MAPK1 | |
| Ethylene Glycol SCHEMBL21616542 | 0.72 | TDP1 (0.43) | TDP1TSHRALDH1A1RECQLGAA | |
| SCHEMBL13169411 | 0.72 | MAOB (0.41) | TDP1ALDH1A1CA1CA2FFAR1 | |
| SCHEMBL3684087 | 0.72 | ALDH1A1 (0.46) | TDP1TSHRALDH1A1CA1CA2 | |
| SCHEMBL28209224 | 0.72 | MAOA (0.44) | — | |
| SCHEMBL1274186 | 0.70 | LTA4H (0.38) | TDP1TSHRMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120059264-A | Universal functional coating material and preparation method thereof | 陕西师范大学 | 2025-05-30 | — | — | CN | claimed |
| CN-120059264-A | Universal functional coating material and preparation method thereof | 陕西师范大学 | 2025-05-30 | — | — | CN | disclosed |
| US-20130204027-A1 | PRODUCTION OF SILAOXACYCLES | WACKER CHEMIE AG (DE) | 2013-08-08 | — | — | US | disclosed |
| EP-2192116-A1 | INDAZOLE ACRYLIC ACID AMIDE COMPOUND | Mitsubishi Tanabe Pharma Corporation (JP) | 2010-06-02 | — | — | EP | disclosed |
| EP-0846127-A1 | ACYLATED OLIGOPEPTIDE DERIVATIVES HAVING CELL SIGNAL INHIBITING ACTIVITY | Novartis AG (CH) | 1998-06-10 | — | — | EP | disclosed |
| WO-1997008193-A1 | ACYLATED OLIGOPEPTIDE DERIVATIVES HAVING CELL SIGNAL INHIBITING ACTIVITY | NOVARTIS AG (CH) | 1997-03-06 | — | — | WO | disclosed |
| WO-1997007131-A1 | ACYLATED OLIGOPEPTIDES CONTAINING PHOSPHOTYROSINE AS INHIBITORS OF PROTEIN TYROSINE KINASES | NOVARTIS AG (CH) | 1997-02-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130204027-A1 | PRODUCTION OF SILAOXACYCLES | OSTC, POLR2E, HAO2 | TDP1 3930/4885TSHR 3020/4885ALDH1A1 1736/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.